Orthofix Medical Inc., a prominent global medical technology company, has announced the global commercial launch of its TrueLok Elevate Transverse Bone Transport $(TBT)$ System. This innovative device marks a significant milestone as the first commercially available system in the U.S. for the TBT procedure, providing a limb preservation treatment option for bony or soft tissue deformities, including diabetic ulcers. The launch follows FDA clearance and CE registration, with over 130 procedures already completed globally during a limited market release. This expansion is part of Orthofix's strategy to lead in limb reconstruction and address the growing diabetic wound market.